Mapping consent practices for outpatient psychiatric use of ketamine.
Journal of Affective Disorders September 1, 2022 David S. Mathai, Scott M Lee, Victoria Mora et al. 16 citations
Given increasing community-based and off-label use of ketamine for psychiatric indications, we examined current informed consent processes from a convenience sample of outpatient ketamine clinics to identify areas of congruence with current evidence and opportunities for growth. Using a rubric developed from existing practice guidelines, we conducted an exploratory analysis of informed consent...